Biopôle Lausanne is one of the largest life sciences campus in Europe, hosting a vibrant community of world-renowned industry players and research institutes, based in Lausanne, Switzerland (www.biopole.ch). It offers a world-class combination of modern infrastructure (134,000 sqm of office/lab space), added value services, an extensive network, innovation and funding programmes, and unparalleled community engagement where members can thrive and bring science to life. Biopôle houses 130+ life sciences companies, including 50 biotech/pharma such as Ferring, Roche, Ichnos, etc. and world-class research organizations (Lausanne University Hospital (CHUV), University of Lausanne (UNIL), the Ludwig Institute for Cancer Research etc.), a life science incubator (StartLab), ready-to-move-in private labs (Superlab), a Digital Health Hub (DH2) enabling the emergence of outstanding innovation for the betterment of healthcare. Join Biopôle.
Biogénesis Bagó S.A.
We are a biotechnology company specialized in the development, production and commercialization of solutions for animal and environmental health. We aim to collaborate in strengthening the sanitary status of each country, fostering new productive developments, and ensuring animal, human and environmental welfare. Our products are present in over 60 countries in America, Asia, Europe, the Middle East, North Africa and Oceania. We are a team of +1000 collaborators worldwide, with a modern management that integrates multiple nationalities. We are supported by our background and constant evolution. We are driven by an inquisitive spirit in the pursuit of anticipating and thinking innovative solutions for animal health issues, through different business models. We work with various international institutions to achieve innovative solutions that allow us to properly address the specific animal health needs of each context. We have a top-notch professional technical service that supports and assists producers and veterinarians to apply technologies correctly. By means of our knowledge and experience, we contribute to improve productivity rates and animal care. At Biogénesis Bagó we work aligned with the concept of “One Health”, which establishes that “human health and animal health are interdependent and linked to the ecosystem in which they coexist” We are committed to the prevention, control and elimination of zoonoses in different regions of the world. We are continuously working on prevention programs through the use of safe, effective, and quality vaccines, thus providing health to all species we focus on. Our vaccine against foot-and-mouth disease is recognized as a world-class product that meets the highest quality standards, validated by the most demanding health authorities. We are one of the main providers of anti-rabies, canine and feline, vaccines for organizations that attend public health campaigns.
BIOCLONAL
BioClonal is a Spanish biotech company enabling immune responses against disease targets that were previously considered out of reach. Founded in 2022 and based in Zaragoza, BioClonal has developed a proprietary platform that unlocks the generation of high-affinity monoclonal antibodies and antigen-specific immune responses, even against the most complex or poorly immunogenic targets. Our technology can be applied in both therapeutic antibody development and next-generation vaccines, offering a versatile solution for tackling diseases with high unmet medical need. We are currently advancing a first-in-class antibody candidate for Alzheimer’s disease and are open to R&D collaborations, co-development, and licensing partnerships. BioClonal operates from its own labs and is actively engaging with pharma, biotech, and academic partners to expand the reach of its discovery engine.
BIO3S Co., Ltd
BIO3S Co., Ltd. is a biotechnology company specializing in antiviral solutions and specimen collection systems. With proprietary plant-derived virus-binding technologies, BIO3S develops products that ensure safe hygiene and accurate diagnostics, including the NORO-X Foaming Hand Soap and OralMax® Oral Specimen Collection Kit. BIO3S is a trusted supplier to public institutions and is expanding into digital healthcare. Virus-Binding Protein Technology for Hygiene and Diagnostics – BIO3S’s Dual Application in Hand Hygiene and Oral Diagnostics At the heart of BIO3S’s innovation lies its proprietary virus-binding lectin protein, extracted from sword beans (Canavalia gladiate), which demonstrates strong affinity for viral surface proteins. This powerful natural compound serves as the foundation for two of BIO3S’s flagship products: the NORO-X Foaming Hand Soap and the OralMax® Oral Specimen Collection Kit—each tailored to a different phase of viral control, from prevention to detection.
Bioagile Therapeutics Private Limited
BioAgile Therapeutics Pvt Ltd is a full fledged Clinical Research Organization based in India providing an end to end clinical research and pharmacovigilance services to pharmaceutical, nutraceutical, biotech, herbs, cosmetics and medical device industries. We have the expertise in conducting trials and have strong affiliations with multiple investigators across diverse therapeutic domains, we excel in delivering excellence from phase I to phase IV, safety, efficacy and label claims assessment. Our services also encompasses pharmacovigilance services such as case processing, signal detection, aggregate reporting and regulatory compliance. With a proven track record of conducting trials and over 120 studies successfully completed, along with 30 national and international publications, we offer unparalleled expertise. | BioAgile Therapeutics Pvt. Ltd. is a full-fledged Clinical Research Organization (CRO) based in India, offering comprehensive, end-to-end clinical research services to the pharmaceutical, nutraceutical, biotech, herbal, cosmetics, and medical device industries. We are committed to delivering scientifically robust, ethically sound, and regulatory-compliant clinical solutions tailored to meet the diverse needs of our clients. Our core services encompass the entire spectrum of clinical development—ranging from Phase I to Phase IV clinical trials. In addition, we specialize in safety, efficacy, and label claims assessment studies, particularly relevant for the nutraceutical, herbal, medical device and cosmetic segments. Our capabilities are backed by a team of experienced professionals and a strong network of investigators across a wide range of therapeutic areas. BioAgile takes pride in its proven track record, having successfully completed over 130 clinical studies to date. Our scientific contributions are further reflected in 30+ publications featured in reputed national and international journals. These accomplishments underscore our dedication to quality, data integrity, and timely project execution. With a strong focus on innovation, collaboration, and regulatory excellence, BioAgile Therapeutics continues to be a trusted partner for clinical development programs in India and globally.
Bimini Pet Health
Bimini Pet Health is a contract manufacturer for dog and cat health supplements, treats and pet food based in Topeka, Kansas. The company manufactures products in different formats soft chews, powders, bars, liquids, Oils and baked goods. Bimini supports the products of over 50 third-party brands sold through platforms including Amazon and Chewy among others. The company is FDA and USDA registered and inspected and third-party audited according to 21 CFR Part 117 (human food) and the National Animal Supplements Council (NASC). In addition to being a contract manufacturer Bimini Pet Health recently launched it’s own premium veterinary brand “Bimini’s Best” featuring patent protected, trademarked and dog and cat efficacy-tested finished products and ingredients. Bimini welcomes inquiries from prospective clients who are seeking to manufacture high quality, innovative products. The company is also seeking partnerships to help ensure the success of it’s brand in the marketplace. | Bimini Pet Health is a pet health supplement and health treat contract manufacturer offering branded products and non-branded products available for private label. Our products come in the forms of soft chews, powders, baked treats, oils and liquids. Everything is produced in our, cGMP certified, USDA inspected and FDA registered manufacturing facilities with responsibly procured ingredients from US-based companies or provided by the client. Bimini is also an audited member of NASC. Bimini is committed to providing private label and custom manufactured pet supplements and health treats designed to support and maintain healthy and happy dogs, cats and horses. Our human grade, dosage form pet health supplements are compliant with 21CFR part 117 – cGMP Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food – and NASC cGMPs modeled after 21CFR 111 & 507 of the Federal Food, Drug and Cosmetic Act for Feed Supplements and Dosage Form Animal Health Products.
Bicoll GmbH
At Bicoll, we are committed to delivering breakthrough solutions in longevity and improving the lives of patients with neurodegenerative disorders such as epilepsy. Our innovative and efficient multi-disciplinary technology approach to the discovery of novel potent molecules for the pharmaceutical, nutraceutical, and agricultural industry is second to none. With a proven track record of success, Bicoll’s plant-based small molecule libraries have been documented in peer-reviewed publications and patents, demonstrating their efficacy in a wide range of applications. Looking to stay ahead of the curve in the highly competitive field of pharmaceuticals? Look no further than Bicoll, the expert in the field of plant small molecules backed up by strong medicinal chemistry. | At Bicoll we’re committed to pushing the boundaries of innovation and harnessing the power of existing compounds to address pressing healthcare challenges. Our latest endeavors in one of the projects have shown promising achievement for the landscape of anti-inflammatory treatments, CNS and taste-modulation. 1. We’re delving deep into the vast pool of existing compounds, uncovering hidden potentials and repurposing them for anti-inflammatory purposes. 2. Our dedicated team of researchers is employing cutting-edge techniques and methodologies to identify compounds with promising anti-inflammatory properties and novel pathways and mechanisms of action. 3. Collaboration is at the heart of our project. By partnering with esteemed institutions and industry experts, we’re fostering synergies and pooling our collective expertise to drive meaningful progress. Our ultimate goal extends beyond scientific advancement. A pioneer in the realm of drug discovery: it has consistently demonstrated unparalleled proficiency in the extraction and isolation of bioactive compounds from natural sources. I. Agriculture: Explore new horizons in agriculture through a strategic partnership with Bicoll. Pioneering novel structures and small molecules that can elevate your compound discovery program II. Adapalene re-purposing: Partnership/out-licensing for a re-purposing small molecule with clear mode of action and IP (patent published) III. Nutraceuticsls – Taste and flavor: Innovate and formulate new alternatives to the ingredients that are the target of sugar taxes. Creating novel sweeteners, flavor enhancers, or other compounds IV. Neuroscience: New chemical entity in the preclinical development: antiepileptic drugs for companion animals. 4NEURON – new spin-off – lead small molecule to change the lives of 50 Mio. Epilepsy patients. V. Compound library and medicinal chemistry: Uncover “dark matter” of medicinal plants. Fresh ideas for your screening | Bicoll is a trusted leader in biopharmaceutical drug discovery, specializing in high-tech natural product and medicinal chemistry to identify novel, small-molecule compounds that power the future of pharmaceuticals and beyond. Leveraging advanced techniques in natural compound identification and chemical synthesis, Bicoll accelerates the discovery of new drug candidates, providing companies with unique, high-potential compounds for preclinical research. Bicoll’s expertise extends to transformative solutions across pharmaceuticals, cosmetics, nutraceuticals, and agriculture, enabling partners to achieve breakthrough results with safe, effective, and innovative products. From Breakthrough Ideas to Life-Changing Solutions: See You at #BIO2025 in San Francisco! Not long ago, a family struggling with epilepsy shared their story with us—a story of endless challenges, countless medications, and the hope for a better future. Stories like theirs drive our mission at Bicoll every day: to turn complex scientific challenges into life-changing breakthroughs. The Problem: Discovering innovative treatments for conditions like epilepsy isn’t just about science—it’s about the people waiting for answers. At Bicoll, we believe in breaking barriers in drug discovery to deliver those answers faster, safer, and more effectively. The Solution: After years of relentless research, our team developed a game-changing small molecule. Tested in acute viable brain slices from multi-drug-resistant epilepsy patients, it has shown exceptional anti-seizure efficacy and an extraordinary reduction in side effects. This isn’t just progress; it’s a leap toward redefining epilepsy care and restoring hope. The Bigger Picture: Bicoll’s innovative approach to natural product and medicinal chemistry extends beyond epilepsy. From pharmaceuticals to cosmetics, nutraceuticals, and agriculture, we’re unlocking the potential of nature to create high-impact, safe, and transformative solutions.
Bactools Biotech S.R.L.
Imagine a future where agriculture feeds the planet—without poisoning the soil that feeds us. Where farmers don’t have to choose between high yields and a healthy ecosystem. This is not a fantasy. This is the mission of Bactools. At Bactools, we believe that the most powerful technology for the future of farming isn’t synthetic. It’s biological. Microorganisms, carefully selected and tested, can replace harmful chemicals, regenerate degraded soils, and unlock the hidden potential of every hectare. We started in Argentina with one vision: to democratize access to the science of biofertilization. With our own plant, R&D team, and a clear purpose, we built not just products—but tools to empower farmers across Latin America. Our solutions aren’t just eco-friendly. They’re farmer-friendly: easy to use, reliable, and made to perform. Bactools is not just about microbes. It’s about changing the narrative. From extractive to regenerative. From commodity to community. And from inputs to impact.